Vaginal colonization by probiotic lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous lactobacilli

Journal of Infectious Diseases

Volumn 199, Issue 10, 2009, Pages 1506-1513

  Antonio, May A D ^a   Meyn, Leslie A ^a   Murray, Pamela J ^a,b   Busse, Barbara ^b   Hillier, Sharon L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CTV 05; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CLINICAL TRIAL; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; FEMALE; FOLLOW UP; HUMAN; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SAFE SEX; SEXUAL BEHAVIOR; SPERM; UNSAFE SEX; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; VAGINA DISCHARGE; VAGINA FLORA; VAGINITIS; YEAST VAGINITIS;

ADOLESCENT; CAPSULES; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROGEN PEROXIDE; LACTOBACILLUS; MALE; NUCLEIC ACID HYBRIDIZATION; PROBIOTICS; SEXUAL BEHAVIOR; VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 65549086207     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598686     Document Type: Article

References (33)

1. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2008; 35:78-83.
2. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-63.
3. Hillier S, Marrazzo J, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill, 2008:737-68.
4. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37:319-25.
5. Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004; 190: 1059-67.
6. Watts DH, Fazzari M, Minkoff H. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005; 191:1129-39.
7. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12:1699-706.
8. Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005; 192:1372-80.
9. Haggerty CL, Hillier SL, Bass DC, Ness RB. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis 2004; 39:990-5.
10. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256:1899-903.
11. Hay PE, Lamont RF, Taylor-Robinson D, et al. Abnormal bacterial colonization of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308:295-8.
12. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995; 333:1737-42.
13. Lahli-Camp JM, Rai R, Ison C, et al. Association of bacterial vaginosis with history of second trimester miscarriage. Human Reprod 1996; 11: 1575-8.
14. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353:1899-911.
15. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 1478-86.
16. Austin MN, Beigi RH, Meyn LA, Hillier SL. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 2005; 43:4492-7.
17. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35:131-4.
18. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentum RC-14 and L. rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol 2002; 9:92-6.
19. Antonio MAD, Hillier SL. DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 2003; 41:1881-7.
20. Kiss H, Kögler B, Petricevic L, et al. Vaginal Lactobacillus microbiota of healthy women in the late first trimester of pregnancy. BJOG 2007; 114: 1402-7.
21. Wilks M, Wiggins R, Whiley A, et al. Identification andH2O2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol 2004; 42:713-7.
22. McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol 1993; 6:251-64.
23. Antonio MAD, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005; 192:394-8.
24. Song Y, Kato N, Matsumiya Y, Liu C, Kato H, Watanabe K. Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol 1999; 37:3062.
25. Giorgi A, Torriani S, Dellaglio F, Bo G, Stola E, Bernuzzi L. Identification of vaginal lactobacilli from asymptomatic women. Microbiologica 1987; 10:377-84.
26. Vásquez A, Jakobsson T, Ahrné S, Forsum U, Molin G. Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002; 40: 2746-9.
27. Vallor AC, Antonio MAD, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 2001; 184:1431-6.
28. Kwok L, Stapleton AE, Stamm WE, Hillier SL, Wobbe CL, Gupta K. Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urol 2006; 176:2050-4.
29. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
30. Toth A, O'Leary WM, Ledger W. Evidence of microbial transfer by spermatozoa. Obstet Gynecol 1982; 59:556-9.
31. Eschenbach DA, Patton DL, Hooton TM, Meier AS, et al. Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis 2001; 183:913-8.
32. Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003; 69:97-101.
33. Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol 2007; 2007:35387.